GB2144409A - Preparation of 5'-deoxy-5'-methylthioadenosine - Google Patents
Preparation of 5'-deoxy-5'-methylthioadenosine Download PDFInfo
- Publication number
- GB2144409A GB2144409A GB08321947A GB8321947A GB2144409A GB 2144409 A GB2144409 A GB 2144409A GB 08321947 A GB08321947 A GB 08321947A GB 8321947 A GB8321947 A GB 8321947A GB 2144409 A GB2144409 A GB 2144409A
- Authority
- GB
- United Kingdom
- Prior art keywords
- deoxy
- aqueous solution
- methylthioadenosine
- methionine
- same
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
A method of preparing 5'-deoxy-5'-methylthiodenosine comprises hydrolysing a concentrated aqueous solution of S-adenosyl-methionine by heating under reflux, neutralising the reaction mixture and cooling it to separate the 5'-deoxy-5'-methylthioadenosine formed.
Description
1 GB 2 144 409 A 1
SPECIFICATION
Preparation of 5'-deoxy-S'-methyithioadenosine This invention is concerned with improvements in and relating to 5'-deoxy- 5'-methyithioadenosine. In our copending application No. 8112428 we describe and claim therapeutic compositions of antiffif lammatory, analgesic and antipyretic activity in dosage unit form and containing, from 25 to 100.2 mg of an active principle of the general formula:
HH-Rl c W H LH2--K 0 OR2 OR2 (1) in which: R is a linear or branched alkyl radical containing 1-18 C atoms or a phenylalkylene radical in which the alkylene chain contains 1-6 C atoms; R, is H, an aliphatic acyl radical containing 1-6 C atoms or an aromatic acyl radical; R2 is H; and n is 0 or 1. Of all the products prepared, the one which has proved particularly interesting is 5'-deoxy- 5'methylthioadenosine (MTA) of the formula:
NH2 0 ON ON EN2-S-EN3 (H) A method has been found for preparing this product which is particularly simple and economical from an industrial viewpoint. The new process consists essentially of carrying out hydrolysis of Sadenosyimethionine (SAME) under strictly controlled critical conditions, which lead to practically total hydrolysis and complete crystallisation of the IVITA 1H2 NH2 j 1 H20 CH -S-CH -CH - CH - COON H N 2 2 2 Y0 CH3 ON ON N 1. ' J > CH -5-CH N H 0 2 3 ON ON NH2 1 HO-Ln-Lt'2LM-LOOH+H+ GB 2 144 409 A The controlled hydrolysis process can be applied to SAME prepared in any manner.
However, the method of preparation of the SAME solution is also an influencing factor in carrying out the new process in an economically convenient manner.
The following operational stages provide the most economical embodiment of the process:
(a) Normal bread yeast is enriched in SAME by treatment with methionine in accordance with the Schienk method (Schlenk F (1975) Enzymologie 29, 283).
(b) The yeast cells suspended in water are lysed by treatment with ethyl or methyl acetate at ambient temperature (DT-OS P23 36401.4).
By adjusting the pH to between 4 and 6 and filtering, an aqueous solution is obtained containing practically ail the SAME present in the initial yeast.
(c) The solution is concentrated under vacuum at 35-40'C to about 1/10 of its initial volume.
(d) The concentrate is boiled uner reflux for about 30 minutes and the pH is adjusted to 7 with soda.
(e) The solution is left to stand at 0 - WC, and the precipitated IVITA is collected practically completely and in good purity.
The steps of c, d and e, which as stated are critically necessary for obtaining complete selective hydrolysis 15 of SAME to MTA without formation of by-products, are new.
The following example illustrates the present invention.
Example
Preparation of 5'-deoxy-5'-methylthioadenosine(MTA) 11 litres of ethyl acetate and 11 litres of water at ambient temperature are added to 90 kg of bread yeast which has been enriched in SAME by adding methionine until the SAME content is 6.88 glkg. After energetic stirring for 30 minutes, the pH is adjusted to 4.5 with dilute H2S04, the mixture is filtered and the residue is washed with waterto give 140 litres of solution with a SAME content of 4. 40 g/1, equal to 99.5% of the SAME present in the initial material.
The lysate thus obtained is concentrated under vacuum (30 mm Hq; 35-40'C) to a volume of about 14 litres.
The concentrated solution is boiled under reflux at normal pressure for 30 minutes. It is cooled to 20'C, the pH adjusted to 7 with 40% by weight soda, andleft overnight in a refrigeration cell (+3'C). A white precipitate is formed which is filtered, dissolved in 10 litres of boiling distilled water and crystallised by cooling this solution. 410 g of crystalline MTA of high purity are obtained, equal to a yield of 90% with respect to the 30 SAME subjected to hydrolysis.
The characteristics of the product obtained coincide with those of pure MTA obtained by other means.
Claims (3)
1. A process for preparing 5'-deoxy-5'-methyi-thioadenosine, wherein Sadenosyl-methionine in concentrated aqueous solution, is hydrolysed by heating under reflux, and the 5'-deoxy-5'-methyithioadenosine formed is precipitated from the aqueous solution by cooling after neutralising the reaction mixture.
2. A process as claimed in claim 1 wherein the aqueous solution of Sadenosyl-methionine is 40 concentrated by heating under vacuum to 35 40'C.
3. A process as claimed in claim 2 or claim 3, wherein the 5'-deoxy-5'methyithioadenosine formed is precipitated by cooling to O-WC.
Printed in the UK for HMSO, D8818935, 1185, 7102. Published by The Patent Office, 25 Southampton Buildings, London, WC2A lAY, from which copies may be obtained.
t
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT21550/80A IT1193529B (en) | 1980-04-22 | 1980-04-22 | ADENOSINIC DERIVATIVES FOR ANTI-INFLAMMATORY AND ANALGESIC ACTIVITIES AND THERAPEUTIC COMPOSITIONS THAT CONTAIN THEM AS AN ACTIVE PRINCIPLE |
Publications (3)
Publication Number | Publication Date |
---|---|
GB8321947D0 GB8321947D0 (en) | 1983-09-14 |
GB2144409A true GB2144409A (en) | 1985-03-06 |
GB2144409B GB2144409B (en) | 1985-09-11 |
Family
ID=11183457
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB8112428A Expired GB2074446B (en) | 1980-04-22 | 1981-04-22 | Adenosine derivatives of antiinflammatory and analgesic activity and therapeutic compositions containing them |
GB08321947A Expired GB2144409B (en) | 1980-04-22 | 1983-08-15 | Preparation of 5'-deoxy-5'-methylthioadenosine |
GB08413454A Expired GB2144038B (en) | 1980-04-22 | 1984-05-25 | Adenosine derivatives of anti-inflammatory and analgesic activity and therapeutic compositions containing them |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB8112428A Expired GB2074446B (en) | 1980-04-22 | 1981-04-22 | Adenosine derivatives of antiinflammatory and analgesic activity and therapeutic compositions containing them |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB08413454A Expired GB2144038B (en) | 1980-04-22 | 1984-05-25 | Adenosine derivatives of anti-inflammatory and analgesic activity and therapeutic compositions containing them |
Country Status (17)
Country | Link |
---|---|
JP (2) | JPS56166117A (en) |
AR (1) | AR231144A1 (en) |
BE (1) | BE888472A (en) |
CA (1) | CA1198105A (en) |
CH (2) | CH650514A5 (en) |
DE (1) | DE3116067A1 (en) |
DK (1) | DK159453C (en) |
ES (2) | ES8206551A1 (en) |
FI (1) | FI70227C (en) |
FR (1) | FR2491761A1 (en) |
GB (3) | GB2074446B (en) |
IT (1) | IT1193529B (en) |
LU (1) | LU83307A1 (en) |
MX (1) | MX9203630A (en) |
NL (1) | NL192111C (en) |
NO (1) | NO150515C (en) |
SE (3) | SE460198B (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1177373B (en) * | 1984-12-06 | 1987-08-26 | Bioresearch Spa | SALTS OF 5'-METHYLLIUM-5'-DEOXYDENOSINE WITH LONG ALCHYLIC CHAIN SULPHONIC ACIDS |
IT1227049B (en) * | 1988-07-29 | 1991-03-14 | Bioresearch Spa | USE OF ADENOSINIC DERIVATIVES FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS HAVING IMMUNOSTIMULATING ACTIVITIES. |
JPH0497287A (en) * | 1990-08-10 | 1992-03-30 | Nec Ic Microcomput Syst Ltd | Picture display integrated circuit |
ES2334924T3 (en) * | 2005-03-17 | 2010-03-17 | Proyecto De Biomedicina Cima, S.L. | EMPLOYMENT OF 5'-METHYLTIOADENOSINE (MTA) IN THE PREVENTION AND / OR TREATMENT OF AUTOIMMUNE DISEASES AND / OR REJECTION OF TRANSPLANTS. |
ES2259552B1 (en) * | 2005-03-17 | 2007-06-16 | Proyecto De Biomedicina Cima, S.L. | EMPLOYMENT OF 5'-METHYLTIOENENINE (MTA) IN THE PREVENTION AND / OR TREATMENT OF AUTOIMMUNE DISEASES AND / OR REPLACEMENT OF TRANSPLANTS. |
DE102010027595A1 (en) * | 2010-07-23 | 2012-01-26 | Helmut Vorbrüggen | Clinical application of adenosine derivative, preferably (dihydroxyphenyl)ethyl-amino-purin-9-yl-(hydroxymethyl)oxolane-diol, for reducing body temperature during impending ischemia of brain vessels, which occur during heart attacks |
DE102011005232A1 (en) * | 2011-03-08 | 2012-09-13 | AristoCon GmbH & Co. KG | Adenosine and its derivatives for use in pain therapy |
JP6214628B2 (en) * | 2013-04-05 | 2017-10-18 | ライオン株式会社 | Oral composition |
WO2014163152A1 (en) * | 2013-04-05 | 2014-10-09 | ライオン株式会社 | Non-rem sleep-promoting agent, deep sleep-promoting agent and natural sleep-inducing agent |
WO2014163151A1 (en) * | 2013-04-05 | 2014-10-09 | ライオン株式会社 | Yeast culture, and composition for internal application |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1259341B (en) * | 1962-12-22 | 1968-01-25 | Boehringer & Soehne Gmbh | Process for the preparation of new 5'-sulfoxides of nucleosides |
DE1545645A1 (en) * | 1965-12-06 | 1969-08-21 | Boehringer Mannheim Gmbh | Process for the preparation of disubstituted adenosine derivatives |
FR2252405B1 (en) * | 1973-11-27 | 1978-04-28 | Ajinomoto Kk | |
FR2313937A1 (en) * | 1975-06-09 | 1977-01-07 | Anvar | DRUG BASED ON 5 'THIOETHERS OF ADENOSINE |
FR2424027A1 (en) * | 1978-04-28 | 1979-11-23 | Merieux Inst | NEW MEDICINAL PRODUCT, IN PARTICULAR SEDATIVE AND SLEEP INDUCER AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT |
-
1980
- 1980-04-22 IT IT21550/80A patent/IT1193529B/en active
-
1981
- 1981-04-17 BE BE0/204529A patent/BE888472A/en not_active IP Right Cessation
- 1981-04-21 ES ES501539A patent/ES8206551A1/en not_active Expired
- 1981-04-21 AR AR285020A patent/AR231144A1/en active
- 1981-04-21 NO NO811346A patent/NO150515C/en unknown
- 1981-04-21 CA CA000375784A patent/CA1198105A/en not_active Expired
- 1981-04-21 LU LU83307A patent/LU83307A1/en unknown
- 1981-04-21 JP JP5930181A patent/JPS56166117A/en active Granted
- 1981-04-21 SE SE8102489A patent/SE460198B/en not_active IP Right Cessation
- 1981-04-21 DK DK176481A patent/DK159453C/en not_active IP Right Cessation
- 1981-04-22 GB GB8112428A patent/GB2074446B/en not_active Expired
- 1981-04-22 CH CH4716/84A patent/CH650514A5/en not_active IP Right Cessation
- 1981-04-22 CH CH263281A patent/CH645544A5/en not_active IP Right Cessation
- 1981-04-22 FR FR8107992A patent/FR2491761A1/en active Granted
- 1981-04-22 DE DE19813116067 patent/DE3116067A1/en active Granted
- 1981-04-22 NL NL8101984A patent/NL192111C/en not_active IP Right Cessation
- 1981-04-22 FI FI811249A patent/FI70227C/en not_active IP Right Cessation
-
1982
- 1982-04-01 ES ES511039A patent/ES8306378A1/en not_active Expired
-
1983
- 1983-08-15 GB GB08321947A patent/GB2144409B/en not_active Expired
-
1984
- 1984-05-25 GB GB08413454A patent/GB2144038B/en not_active Expired
-
1987
- 1987-03-04 SE SE8700914A patent/SE464635B/en not_active IP Right Cessation
- 1987-03-04 SE SE8700913A patent/SE466238B/en not_active IP Right Cessation
-
1989
- 1989-02-02 JP JP1022771A patent/JPH01301692A/en active Granted
-
1992
- 1992-06-26 MX MX9203630A patent/MX9203630A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Fox et al. | Pyrimidine nucleosides. I. A new route for the synthesis of thymine nucleosides1 | |
HU193893B (en) | Process for preparing antiviral 2-deoxy-2,2-difluoropentozyl nucleoside derivatives | |
GB2144409A (en) | Preparation of 5'-deoxy-5'-methylthioadenosine | |
JPS5877881A (en) | Antiviral compound | |
HU203363B (en) | Process for producing 2',3'-dideoxy-2',2'-difluoronucleosides and pharmaceutical compositions comprising same as active ingredient | |
AU2010233367A1 (en) | 6"-sialyllactose salts and process for their synthesis and for the synthesis of other a-sialyloligosaccharides | |
COXON et al. | Simplified preparation of sophorose (2-O-β-d-glucopyranosyl-d-glucose) | |
US4373097A (en) | Process for preparing adenosine derivatives of anti-inflammatory and analgesic activity | |
EP0184248A2 (en) | Salts of 5'-methylthio-5'-deoxyadenosine with long-alkyl chain sulphonic acids | |
HU199502B (en) | Process for producing new purine derivatives and pharmaceutical compositions comprising same | |
JPH05247078A (en) | Sugar compound, sialic acid-containing sugar chain biosyhnthesis inhibitor, its production, and new intermediate | |
Wolfrom et al. | Synthesis of 2-Amino-2-deoxy-L-arabinose (L-Arabinosamine) | |
US4873223A (en) | Zinc salt of fructose-1,6-diphosphate | |
US4374831A (en) | Modulators of the complement system comprising bis-glucopyranosyl arylene sulfate derivatives | |
GR3002313T3 (en) | Compositions for therapeutical use containing organo-silico-compounds | |
CA2110707A1 (en) | Immunosuppressive and tolerogenic oligosaccharide modified lewis x and lewis a compounds | |
EP0330625A3 (en) | Total synthesis method for making an indole structure derivative product class, of the triptamine type, in particular, melatonin or N-acetyl-5-methoxytriptamine type, having a high purity degree and easily soluble, for therapeutic use against acquired immuno-deficiency syndromes | |
Leclercq et al. | Synthesis and Biological Activity of a Fluoroketonucleoside: 7-(3-Deoxy-3-fluoro-β-d-glycero-hex-2-enopyranosyl-4-ulose) theophylline | |
JPS57102889A (en) | 2'-(r)-substituted-2'-deoxyneplanocin a derivative | |
US3642771A (en) | 5-benzyl - (2'-desoxyribosyl) uracil compounds compositions containing same and process of making and using same | |
WO1980000444A1 (en) | Hydroxamic acid derivatives | |
FI68629B (en) | FOERFARANDE FOER FRAMSTAELLNING AV 5'-DEOXY-5'-METHYLTIOADENOSIN | |
US3522237A (en) | Method for the preparation of o - substituted - 6 - azacytidines and 6-azacytidine | |
JPS62148476A (en) | Thiadiazole antiviral | |
PT98167A (en) | PROCESS FOR THE PREPARATION OF PYRIMIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
732E | Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977) | ||
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19970422 |